New Delhi-based Mankind Pharma Limited (NSEI:MANKIND) is planning to acquire Mumbai-based biopharma firm Bharat Serums and Vaccines Limited (BSV) from private equity player Advent PE (Advent International, L.P.), according to media reports. Advent is seeking a $2 billion valuation for the 100% stake it owns in BSV. According to a report by CNBC-TV18, Advent is looking to exit BSV, which has been involved in women's health, critical care and emergency medicines, and assisted reproductive therapies for some time now.

Business Standard was not able to verify the news till the time of going to press. Mankind Pharma's stock surged 3.11% on the Bombay Stock Exchange on May 14, 2024. Emails sent to Mankind Pharma and BSV did not elicit any responses till the time of going to press.

Advent PE refused to comment on the matter.